Chlorpromazine Hydrochloride
- C17H19ClN2S.ClH
- C17H20Cl2N2S
- Chlorpromazine hydrochloride
- 69-09-0
- Chlorpromazine Hcl
- Sonazine
- Chloractil
- Create:2004-09-16
- Modify:2025-01-25
- Aminazine
- Chlorazine
- Chlordelazine
- Chlorpromazine
- Chlorpromazine Hydrochloride
- Contomin
- Fenactil
- Hydrochloride, Chlorpromazine
- Largactil
- Propaphenin
- Thorazine
- Chlorpromazine hydrochloride
- 69-09-0
- Chlorpromazine Hcl
- Sonazine
- Chloractil
- Klorproman
- Marazine
- Norcozine
- Klorpromex
- Plegomazin
- Promacid
- Promapar
- Hebanil
- Hibernal
- Hybernal
- Lomazine
- Neurazine
- Promachel
- Promexin
- Taroctyl
- Tranzine
- Chlorpromazinium chloride
- NCI-C05210
- Unitensen
- Chloropromazine monohydrochloride
- Propaphen
- Chlorpromazine (hydrochloride)
- Aminazin monohydrochloride
- Fenactil monohydrochloride
- [3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-dimethylamine hydrochloride
- Ampliactil monohydrochloride
- Hibanil
- CHLOROPROMAZINE HYDROCHLORIDE
- Thorazine hydrochloride
- Chlorpromazine monohydrochloride
- Largaktyl
- CHEBI:3649
- DTXSID7024827
- Chlorpromazine chloride
- 10-(3-Dimethylaminopropyl)-2-chlorophenothiazine monohydrochloride
- 4560 Rp hydrochloride
- Chlorpromazine Hydrochloride Intensol
- MFCD00012654
- 9WP59609J6
- 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine hydrochloride
- MLS000069401
- DTXCID404827
- Phenothiazine hydrochloride
- Chlorpromazine.HCl
- 2-Chloro-10-(3-(dimethylamino)propyl)phenothiazine monohydrochloride
- 3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine;hydrochloride
- NSC17479
- 10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-, monohydrochloride
- NSC-17479
- 69-09-0 (HCl)
- Aminazinum
- Megatil
- SMR000058254
- 2-Chloro-10-(3-dimethylaminopropyl)phenothiazine hydrochloride
- Phenothiazine, 2-chloro-10-(3-(dimethylamino)propyl)-, monohydrochloride
- Chlorpromazine, Hydrochloride
- Contomin hydrochloride
- Megaphen hydrochloride
- 2-Chloro-10-(3-dimethylaminopropyl)phenothiazine monohydrochloride
- Largactil monohydrochloride
- CPZ (VAN)
- CHLORPROMAZINE HYDROCHLORIDE (MART.)
- CHLORPROMAZINE HYDROCHLORIDE [MART.]
- CCRIS 6221
- CHLORPROMAZINE HYDROCHLORIDE (USP-RS)
- CHLORPROMAZINE HYDROCHLORIDE [USP-RS]
- [3-(2-chloro-10H-phenothiazin-10-yl)propyl]dimethylamine hydrochloride
- CAS-69-09-0
- Propaphenin hydrochloride
- CHLORPROMAZINE HYDROCHLORIDE (EP IMPURITY)
- CHLORPROMAZINE HYDROCHLORIDE (EP MONOGRAPH)
- CHLORPROMAZINE HYDROCHLORIDE [EP IMPURITY]
- CHLORPROMAZINE HYDROCHLORIDE [EP MONOGRAPH]
- SR-01000000012
- CHLORPROMAZINE HYDROCHLORIDE (USP MONOGRAPH)
- CHLORPROMAZINE HYDROCHLORIDE [USP MONOGRAPH]
- EINECS 200-701-3
- NSC 17479
- 2-Chloro-10-[3-(dimethylamino)propyl]phenothiazine monohydrochloride
- AI3-28023
- UNII-9WP59609J6
- Prestwick_58
- Sonazine (TN)
- Chlorpromazine HCl?
- 2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine monohydrochloride
- CHLORPROMAZINE HCI
- AC1LCWF1
- Chlorpromazine hydrochloride [USP:BAN:JAN]
- Opera_ID_1294
- Chlorpromazini hydrochloridum
- AMINAZIN HYDROCHLORIDE
- CHEMBL1713
- Hydrochloride, Chlorpromazine
- SCHEMBL41771
- MLS001148603
- MLS002222157
- Chlorpromazin-d6 hydrochloride
- HY-B0407A
- Chlorpromazine hydrochloride, 98%
- HMS1568M09
- BCP30284
- Tox21_300517
- Tox21_500249
- NSC226514
- s2456
- AKOS005111082
- CCG-220064
- CCG-221553
- LP00249
- NC00552
- Chlorpromazine hydrochloride (JP17/USP)
- CHLORPROMAZINE HYDROCHLORIDE [MI]
- NCGC00024409-09
- NCGC00093711-01
- NCGC00093711-02
- NCGC00180973-01
- NCGC00254272-01
- NCGC00260934-01
- AC-10573
- CHLORPROMAZINE HYDROCHLORIDE [JAN]
- LS-14587
- CHLORPROMAZINE HYDROCHLORIDE [VANDF]
- C2481
- CHLORPROMAZINE HYDROCHLORIDE [WHO-DD]
- CHLORPROMAZINE HYDROCHLORIDE [WHO-IP]
- Chlorpromazine hydrochloride, >=98% (TLC)
- EU-0100249
- NS00078900
- SW196373-5
- EN300-20245
- C 8138
- C07952
- Chlorpromazine, Hydrochloride - CAS 69-09-0
- D00789
- D89519
- MLS-0090820.0001
- CHLORPROMAZINE HYDROCHLORIDE [GREEN BOOK]
- WLN: T C666 BN ISJ B3N1&1 EG &GH
- CHLORPROMAZINE HYDROCHLORIDE [ORANGE BOOK]
- CHLORPROMAZINI HYDROCHLORIDUM [WHO-IP LATIN]
- Q-200842
- SR-01000000012-2
- SR-01000000012-9
- Q27106159
- Chlorpromazine.HCl, 1mg/ml in Methanol (as free base)
- Z104477466
- 2-chloro-10-(3-dimethylaminopropyl) phenothiazine hydrochloride
- Chlorpromazine hydrochloride, meets USP testing specifications
- Chlorpromazine hydrochloride, VETRANAL(TM), analytical standard
- 2-Chloro-10-[3-(dimethylamino)-1-propyl]phenothiazine Hydrochloride
- Chlorpromazine Hydrochloride 1.0 mg/ml in Methanol (as free base)
- 10H-phenothiazine-10-propanamine hydrochloride, 2-chloro-N,N-dimethyl-
- Chlorpromazine hydrochloride, European Pharmacopoeia (EP) Reference Standard
- 10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-, hydrochloride (1:1)
- 3-(2-Chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropylamine monohydrochloride
- Chlorpromazine hydrochloride, United States Pharmacopeia (USP) Reference Standard
- PHENOTHIAZINE-10-PROPANAMINE, 2-CHLORO-N,N-DIMETHYL-, MONOHYDROCHLORIDE
- Chlorpromazine (has active moiety)
- Phenothiazine (subclass of)
H301 (99.2%): Toxic if swallowed [Danger Acute toxicity, oral]
H330 (94.6%): Fatal if inhaled [Danger Acute toxicity, inhalation]
P260, P264, P270, P271, P284, P301+P316, P304+P340, P316, P320, P321, P330, P403+P233, P405, and P501
(The corresponding statement to each P-code can be found at the GHS Classification page.)
Aggregated GHS information provided per 129 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.
Acute Tox. 3 (99.2%)
Acute Tox. 2 (94.6%)
SYMPTOMS: This compound can cause severe dermatitis in sensitized persons. It may also cause drowsiness, dryness of mouth, nasal congestion, postural hypotension, lowering of body temperature, tachycardia, arrhythmias, agitation, insomnia, depression, miosis and mydriasis, convulsions, photosensitivity, skin rashes, inhibition of ejaculation, obstructive jaundice, chronic constipation, urinary retention, various hematological disorders, allergic reactions, development of purple pigmentation in exposed skin, deposition of pigment in eyes and altered endocrine functions. It reduces the efficiency of heat regulation such that individuals tend to acquire the temperature of the environment. It also reduces salivary and gastric secretion. It may cause extra-pyramidal effects and sedative (neuroletic) effects which cause suppression of spontaneous movement and complex movements while spinal reflexes and unconditioned nociceptive-avoidance behaviors remain intact.
ACUTE/CHRONIC HAZARDS: This compound is an irritant. It may cause dermatitis in sensitized persons. When heated to decomposition it emits very toxic fumes of chlorine, nitrogen oxides and sulfur oxides. (NTP, 1992)
EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.
SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.
INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. IMMEDIATELY call a physician and be prepared to transport the victim to a hospital even if no symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) should be used; if not available, use a level of protection greater than or equal to that advised under Protective Clothing.
INGESTION: If the victim is conscious and not convulsing, give 1 or 2 glasses of water to dilute the chemical and IMMEDIATELY call a hospital or poison control center. Generally, the induction of vomiting is NOT recommended outside of a physician's care due to the risk of aspirating the chemical into the victim's lungs. However, if the victim is conscious and not convulsing and if medical help is not readily available, consider the risk of inducing vomiting because of the high toxicity of the chemical ingested. Ipecac syrup or salt water may be used in such an emergency. IMMEDIATELY transport the victim to a hospital. If the victim is convulsing or unconscious, do not give anything by mouth, ensure that the victim's airway is open and lay the victim on his/her side with the head lower than the body. DO NOT INDUCE VOMITING. IMMEDIATELY transport the victim to a hospital. (NTP, 1992)
Excerpt from ERG Guide 154 [Substances - Toxic and/or Corrosive (Non-Combustible)]:
IMMEDIATE PRECAUTIONARY MEASURE: Isolate spill or leak area in all directions for at least 50 meters (150 feet) for liquids and at least 25 meters (75 feet) for solids.
SPILL: Increase the immediate precautionary measure distance, in the downwind direction, as necessary.
FIRE: If tank, rail tank car or highway tank is involved in a fire, ISOLATE for 800 meters (1/2 mile) in all directions; also, consider initial evacuation for 800 meters (1/2 mile) in all directions. (ERG, 2024)
SMALL SPILLS AND LEAKAGE: If you spill this chemical, you should dampen the solid spill material with water, then transfer the dampened material to a suitable container. Use absorbent paper dampened with water to pick up any remaining material. Seal your contaminated clothing and the absorbent paper in a vapor-tight plastic bag for eventual disposal. Wash all contaminated surfaces with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.
STORAGE PRECAUTIONS: You should protect this chemical from exposure to light. Keep the container tightly closed under an inert atmosphere, and store under refrigerated temperatures. (NTP, 1992)
RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with a combination filter cartridge, i.e. organic vapor/acid gas/HEPA (specific for organic vapors, HCl, acid gas, SO2 and a high efficiency particulate filter).
RECOMMENDED GLOVE MATERIALS: Permeation Test Results of Diluted Chemical in water (410 mg/mL): If this chemical makes direct contact with your gloves, or if a tear, puncture or hole develops, replace them at once.
Glove Type Model Number Thickness Bkthru Time
PVC Edmont 34-100 0.18 mm 480 min
Latex Ansell 9020-5 0.13 mm 480 min (NTP, 1992)
Amines, Phosphines, and Pyridines
Sulfides, Organic
Salts, Acidic
Aryl Halides
IMAP assessments - 10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-, monohydrochloride: Environment tier I assessment
IMAP assessments - 10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-, monohydrochloride: Human health tier I assessment
Patents are available for this chemical structure:
https://patentscope.wipo.int/search/en/result.jsf?inchikey=FBSMERQALIEGJT-UHFFFAOYSA-N
- Australian Industrial Chemicals Introduction Scheme (AICIS)10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-, monohydrochloridehttps://services.industrialchemicals.gov.au/search-assessments/
- CAMEO ChemicalsLICENSECAMEO Chemicals and all other CAMEO products are available at no charge to those organizations and individuals (recipients) responsible for the safe handling of chemicals. However, some of the chemical data itself is subject to the copyright restrictions of the companies or organizations that provided the data.https://cameochemicals.noaa.gov/help/reference/terms_and_conditions.htm?d_f=falseCHLORPROMAZINE HYDROCHLORIDEhttps://cameochemicals.noaa.gov/chemical/20027CAMEO Chemical Reactivity Classificationhttps://cameochemicals.noaa.gov/browse/react
- CAS Common ChemistryLICENSEThe data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.https://creativecommons.org/licenses/by-nc/4.0/Chlorpromazine hydrochloridehttps://commonchemistry.cas.org/detail?cas_rn=69-09-0
- ChemIDplusChlorpromazine hydrochloride [USP:BAN:JAN]https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0000069090ChemIDplus Chemical Information Classificationhttps://pubchem.ncbi.nlm.nih.gov/source/ChemIDplus
- DTP/NCILICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuseChlorpromazine hydrochloridehttps://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=17479
- EPA Chemicals under the TSCA10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-, hydrochloride (1:1)https://www.epa.gov/chemicals-under-tscaEPA TSCA Classificationhttps://www.epa.gov/tsca-inventory
- EPA DSSToxChlorpromazine hydrochloridehttps://comptox.epa.gov/dashboard/DTXSID7024827CompTox Chemicals Dashboard Chemical Listshttps://comptox.epa.gov/dashboard/chemical-lists/
- European Chemicals Agency (ECHA)LICENSEUse of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.https://echa.europa.eu/web/guest/legal-noticeChlorpromazine hydrochloridehttps://echa.europa.eu/substance-information/-/substanceinfo/100.000.638Chlorpromazine hydrochloride (EC: 200-701-3)https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/7117
- FDA Global Substance Registration System (GSRS)LICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingCHLORPROMAZINE HYDROCHLORIDEhttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/9WP59609J6
- New Zealand Environmental Protection Authority (EPA)LICENSEThis work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International licence.https://www.epa.govt.nz/about-this-site/general-copyright-statement/
- NCI Thesaurus (NCIt)LICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuseNCI Thesaurushttps://ncit.nci.nih.gov
- Open TargetsLICENSEDatasets generated by the Open Targets Platform are freely available for download.https://platform-docs.opentargets.org/licenceCHLORPROMAZINE HYDROCHLORIDEhttps://platform.opentargets.org/drug/CHEMBL1713
- ChEMBLLICENSEAccess to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).http://www.ebi.ac.uk/Information/termsofuse.htmlChEMBL Protein Target Treehttps://www.ebi.ac.uk/chembl/g/#browse/targets
- Drug Gene Interaction database (DGIdb)LICENSEThe data used in DGIdb is all open access and where possible made available as raw data dumps in the downloads section.http://www.dgidb.org/downloadsCHLORPROMAZINE HYDROCHLORIDEhttps://www.dgidb.org/drugs/rxcui:104728
- ClinicalTrials.govLICENSEThe ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use
- DailyMedCHLORPROMAZINE HYDROCHLORIDEhttps://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=CHLORPROMAZINE+HYDROCHLORIDE
- Drugs@FDALICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingCHLORPROMAZINE HYDROCHLORIDEhttps://www.accessdata.fda.gov/scripts/cder/daf/
- FDA Orange BookLICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linking
- KEGGLICENSEAcademic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial licensehttps://www.kegg.jp/kegg/legal.htmlTherapeutic category of drugs in Japanhttp://www.genome.jp/kegg-bin/get_htext?br08301.kegUSP drug classificationhttp://www.genome.jp/kegg-bin/get_htext?br08302.kegAnatomical Therapeutic Chemical (ATC) classificationhttp://www.genome.jp/kegg-bin/get_htext?br08303.kegTarget-based classification of drugshttp://www.genome.jp/kegg-bin/get_htext?br08310.kegDrugs listed in the Japanese Pharmacopoeiahttp://www.genome.jp/kegg-bin/get_htext?br08311.keg
- Metabolomics Workbench
- National Drug Code (NDC) DirectoryLICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingCHLORPROMAZINE HYDROCHLORIDEhttps://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory
- NLM RxNorm TerminologyLICENSEThe RxNorm Terminology is created by the National Library of Medicine (NLM) and is in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from NLM. Credit to the U.S. National Library of Medicine as the source is appreciated but not required. The full RxNorm dataset requires a free license.https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.htmlchlorpromazine hydrochloridehttps://rxnav.nlm.nih.gov/id/rxnorm/104728
- SpectraBaseChlorpromazine HClhttps://spectrabase.com/spectrum/6KyqlV20d3J2-CHLORO-10-[3-(DIMETHYLAMINO)PROPYL]PHENOTHIAZINE,MONOHYDROCHLORIDEhttps://spectrabase.com/spectrum/DgV1t49ZngkCHLORPROMAZINE-HYDROCHLORIDEhttps://spectrabase.com/spectrum/9b1OPlK2vyt2-chloro-10-[3-(dimethylamino)propyl]phenothiazine, monohydrochloridehttps://spectrabase.com/spectrum/3XBMn6cpSWV3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethyl-1-propanaminiumchloridehttps://spectrabase.com/spectrum/8tORP9uItU3Chlorpromazine HClhttps://spectrabase.com/spectrum/EfL5QAaGN7P2-CHLORO-10-[3-(DIMETHYLAMINO)PROPYL]PHENOTHIAZINE, MONOHYDROCHLORIDEhttps://spectrabase.com/spectrum/BrCJXuOErBj
- Springer Nature
- Wikidatachlorpromazine hydrochloridehttps://www.wikidata.org/wiki/Q27106159
- Medical Subject Headings (MeSH)LICENSEWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.https://www.nlm.nih.gov/copyright.htmlChlorpromazinehttps://www.ncbi.nlm.nih.gov/mesh/68002746Antipsychotic Agentshttps://www.ncbi.nlm.nih.gov/mesh/68014150Antiemeticshttps://www.ncbi.nlm.nih.gov/mesh/68000932Dopamine Antagonistshttps://www.ncbi.nlm.nih.gov/mesh/68018492
- PubChem
- GHS Classification (UNECE)GHS Classification Treehttp://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html
- NORMAN Suspect List ExchangeLICENSEData: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0https://creativecommons.org/licenses/by/4.0/NORMAN Suspect List Exchange Classificationhttps://www.norman-network.com/nds/SLE/
- EPA Substance Registry ServicesEPA SRS List Classificationhttps://sor.epa.gov/sor_internet/registry/substreg/LandingPage.do
- MolGenieMolGenie Organic Chemistry Ontologyhttps://github.com/MolGenie/ontology/
- PATENTSCOPE (WIPO)SID 388372777https://pubchem.ncbi.nlm.nih.gov/substance/388372777
- NCBI